GATA2 Deficiency: Early Identification for Improved Clinical Outcomes.


Journal

Clinical journal of oncology nursing
ISSN: 1538-067X
Titre abrégé: Clin J Oncol Nurs
Pays: United States
ID NLM: 9705336

Informations de publication

Date de publication:
01 08 2019
Historique:
entrez: 20 7 2019
pubmed: 20 7 2019
medline: 22 8 2020
Statut: ppublish

Résumé

Patients with GATA2 deficiency present with nontuberculous mycobacterial infections, severe viral infections (particularly refractory human papillomavirus disease), lymphedema, myelodysplastic syndrome (MDS), and acute myeloid leukemia. Patients with GATA2 deficiency who undergo allogeneic hematopoietic stem cell transplantation prior to the development of life-threatening infections or cytogenetic abnormalities may have optimal clinical outcomes. The aim of this article is to determine ways in which oncology nurses can identify GATA2 deficiency in patients early and optimize treatment decisions. A case study is presented of a 33-year-old man with recurrent infections and MDS and his two sons, all of whom were found to have the same GATA2 mutation. Oncology nurses play an important role in early detection and identification by interviewing patients and obtaining a complete and thorough family history.

Sections du résumé

BACKGROUND
Patients with GATA2 deficiency present with nontuberculous mycobacterial infections, severe viral infections (particularly refractory human papillomavirus disease), lymphedema, myelodysplastic syndrome (MDS), and acute myeloid leukemia. Patients with GATA2 deficiency who undergo allogeneic hematopoietic stem cell transplantation prior to the development of life-threatening infections or cytogenetic abnormalities may have optimal clinical outcomes.
OBJECTIVES
The aim of this article is to determine ways in which oncology nurses can identify GATA2 deficiency in patients early and optimize treatment decisions.
METHODS
A case study is presented of a 33-year-old man with recurrent infections and MDS and his two sons, all of whom were found to have the same GATA2 mutation.
FINDINGS
Oncology nurses play an important role in early detection and identification by interviewing patients and obtaining a complete and thorough family history.

Identifiants

pubmed: 31322613
doi: 10.1188/19.CJON.417-422
pmc: PMC8549740
mid: NIHMS1743153
doi:

Substances chimiques

GATA2 Transcription Factor 0
GATA2 protein, human 0

Types de publication

Case Reports Journal Article

Langues

eng

Pagination

417-422

Subventions

Organisme : CCR NIH HHS
ID : HHSN261200800001C
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA SC010384
Pays : United States

Références

Biol Blood Marrow Transplant. 2017 Jun;23(6):863-864
pubmed: 28411176
Semin Hematol. 2017 Apr;54(2):81-86
pubmed: 28637621
Blood. 2011 Sep 8;118(10):2653-5
pubmed: 21670465
Nat Genet. 2011 Sep 04;43(10):1012-7
pubmed: 21892162
Blood. 2011 Sep 29;118(13):3715-20
pubmed: 21816832
Bone Marrow Transplant. 2017 Nov;52(11):1580-1582
pubmed: 28825694
Nat Genet. 2011 Sep 04;43(10):929-31
pubmed: 21892158
Biol Blood Marrow Transplant. 2018 Jun;24(6):1250-1259
pubmed: 29412158
J Nurs Scholarsh. 2005;37(2):98-101
pubmed: 15960052
Biol Blood Marrow Transplant. 2017 Oct;23(10):1669-1677
pubmed: 28602958
Nurs Outlook. 2010 Jan-Feb;58(1):26-35
pubmed: 20113752
Oncol Nurs Forum. 2016 Sep 1;43(5):655-60
pubmed: 27541558
Haematologica. 2018 Aug;103(8):1278-1287
pubmed: 29724903
J Exp Med. 2011 Feb 14;208(2):227-34
pubmed: 21242295
Blood. 2014 Feb 6;123(6):809-21
pubmed: 24227816
Blood. 2011 Sep 8;118(10):2656-8
pubmed: 21765025
Br J Haematol. 2015 Apr;169(2):173-87
pubmed: 25707267
Blood. 2016 Mar 17;127(11):1387-97; quiz 1518
pubmed: 26702063
Am J Hum Genet. 1995 Mar;56(3):745-52
pubmed: 7887430
Pathol Oncol Res. 2018 Jan;24(1):83-88
pubmed: 28357685
Blood. 2014 Feb 6;123(6):863-74
pubmed: 24345756
Am J Med Genet A. 2010 Sep;152A(9):2287-96
pubmed: 20803646
J Pediatr Nurs. 1999 Apr;14(2):130-40
pubmed: 10337125
Blood. 2010 Feb 25;115(8):1519-29
pubmed: 20040766

Auteurs

Kristen Cole (K)

Center for Cancer Research at the National Cancer Institute.

Daniele Avila (D)

Center for Cancer Research at the National Cancer Institute.

Mark Parta (M)

Frederick National Laboratory for Cancer Research.

Bazetta Schuver (B)

Center for Cancer Research at the National Cancer Institute.

Steven Holland (S)

National Institute of Allergy and Infectious Diseases.

Nirali Shah (N)

Center for Cancer Research at the National Institutes of Health.

Dennis Hickstein (D)

Center for Cancer Research at the National Institutes of Health.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH